Clinical evaluation of cefluprenam for treatment of respiratory infections

Kaoru Shimokata, Satoshi Ichiyama, Hideo Saka, Masashi Yamamoto, Masaaki Nagatake, Tetsuya Yagi, Takanao Murate, Kazuyoshi Imaizumi, Eishi Takagi, Naoko Yurikusa

Research output: Contribution to journalArticlepeer-review


Clinical efficacy and safety of cefluprenam (CFLP) were evaluated in 11 patients with respiratory infections. CFLP were administered intravenously 0.5g or 1.0g twice daily. The duration of treatment ranged from 4 to 17 days. Clinical efficacy was excellent in 4, good in 6 and poor in one patient. Skin rash was observed in 1 patient, and abnormal laboratory findings were observed in 2 patients. The results suggest that CFLP is useful for treatment of respiratory infections.

Original languageEnglish
Pages (from-to)298-301
Number of pages4
JournalJapanese Journal of Chemotherapy
Publication statusPublished - 01-01-1995
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Clinical evaluation of cefluprenam for treatment of respiratory infections'. Together they form a unique fingerprint.

Cite this